Pharsight

1. List of Genosyl drug patents

Patent Number	Company	Patent Title	Patent Expiry
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6758214	VERO BIOTECH	Simple nitric oxide generator for ambulatory and/or bedside inhaled no treatment	Feb, 2022 (1 year, 3 months ago)
US11383059	VERO BIOTECH	Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)	Aug, 2025 (2 years from now)
US9522249	VERO BIOTECH	Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)	Aug, 2025 (2 years from now)
US8609028	VERO BIOTECH	Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)	Aug, 2025 (2 years from now)
US9956373	VERO BIOTECH	Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)	Aug, 2025 (2 years from now)
US11291793	VERO BIOTECH	Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)	Aug, 2025 (2 years from now)
US8226916	VERO BIOTECH	Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)	Aug, 2025 (2 years from now)
US10124142	VERO BIOTECH	Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)	Aug, 2025 (2 years from now)
US8821801	VERO BIOTECH	Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)	Aug, 2025 (2 years from now)
US10814092	VERO BIOTECH	Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)	Oct, 2025 (2 years from now)
US8057742	VERO BIOTECH	Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)	Jan, 2026 (2 years from now)
US7618594	VERO BIOTECH	Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)	Oct, 2026 (3 years from now)
US7947227	VERO BIOTECH	Kit for the conversion of nitrogen dioxide (NO2) to nitric oxide (NO)	Oct, 2026 (3 years from now)
US7560076	VERO BIOTECH	Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)	Apr, 2027 (3 years from now)
US9701538	VERO BIOTECH	Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)	Jan, 2029 (5 years from now)
US8944049	VERO BIOTECH	Systems and devices for generating nitric oxide	Aug, 2029 (6 years from now)
US10926054	VERO BIOTECH	Systems and devices for generating nitric oxide	Aug, 2029 (6 years from now)
US9604028	VERO BIOTECH	Systems and devices for generating nitric oxide	Aug, 2029 (6 years from now)
US11103669	VERO BIOTECH	Nitric oxide therapies	Jun, 2030 (7 years from now)
US8607785	VERO BIOTECH	Systems and devices for generating nitric oxide	Jul, 2030 (7 years from now)
US10737051	VERO BIOTECH	Nitrogen dioxide storage device	Oct, 2035 (12 years from now)
US10213572	VERO BIOTECH	Nitrogen dioxide storage cassette	Feb, 2036 (12 years from now)

Do you want to check out GENOSYL patents from before 2022?

Market Authorisation Date: 20 December, 2019

Treatment: A method of delivering nitric oxide to a patient; A method for delivering nitric oxide to a patient with pulmonary hypertension or hypoxia

Dosage: GAS;INHALATION

Strength	Dosage	Availability
800PPM	GAS;INHALATION	Prescription

GENOSYL family patents

United States

Japan

Australia

European Union

Canada

2. List of Genosyl drug patents

Patent Number	Company	Patent Title	Patent Expiry
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11554241	VERO BIOTECH INC	Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)	Aug, 2025 (2 years from now)
US11511252	VERO BIOTECH INC	Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)	Sep, 2029 (6 years from now)

Do you want to check out GENOSYL patents from before 2022?

Market Authorisation Date: 20 December, 2019

Treatment: A method of delivering nitric oxide to a patient

Dosage: GAS;INHALATION

Strength	Dosage	Availability
800PPM	GAS;INHALATION	Prescription

3. List of Inomax drug patents

Patent	Proceeding Filing Date	Status	Respondent	Petitioner
US8282966	March, 2016	Terminated-Denied	Mallinckrodt Hospital Products IP Ltd.	Praxair Distribution, Inc.
US8795741	March, 2016	Terminated-Denied	Mallinckrodt Hospital Products IP Ltd.	Praxair Distribution, Inc.
US8293284	March, 2016	Terminated-Denied	Mallinckrodt Hospital Products IP Ltd.	Praxair Distribution, Inc.
US8431163	March, 2016	Terminated-Denied	Mallinckrodt Hospital Products IP Ltd.	Praxair Distribution, Inc.
US8846112	March, 2016	Terminated-Denied	Mallinckrodt Hospital Products IP Ltd.	Praxair Distribution, Inc.
US8573209	March, 2015	FWD Entered	INO THERAPEUTICS LLC	Praxair Distribution, Inc.
US8776794	March, 2015	FWD Entered	INO Therapeutics LLC	Praxair Distribution, Inc.
US8573210	March, 2015	FWD Entered	INO Therapeutics LLC	Praxair Distribution, Inc.
US8776795	March, 2015	FWD Entered	INO Therapeutics LLC	Praxair Distribution, Inc.
US8291904	March, 2015	FWD Entered	INO Therapeutics LLC	Praxair Distribution, Inc.
US8282966	January, 2015	Terminated-Denied	INO Therapeutics LLC	Praxair Distribution, Inc.
US8293284	January, 2015	Terminated-Denied	INO Therapeutics LLC	Praxair Distribution, Inc.
US8795741	January, 2015	Terminated-Denied	INO Therapeutics LLC	Praxair Distribution, Inc.
US8846112	January, 2015	FWD Entered	INO THERAPEUTICS LLC	Praxair Distribution, Inc.
US8431163	January, 2015	Terminated-Denied	INO THERAPEUTICS LLC	Praxair Distribution, Inc.

Patent Number	Company	Patent Title	Patent Expiry
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8431163	MALLINCKRODT HOSP	Methods of reducing the risk of occurrence of pulmonary edema associated with inhalation of nitric oxide gas	Jun, 2029 (6 years from now)
US8795741	MALLINCKRODT HOSP	Methods for treating patients who are candidates for inhaled nitric oxide treatment	Jun, 2029 (6 years from now)
US8282966	MALLINCKRODT HOSP	Methods of reducing the risk of occurrence of pulmonary edema in children in need of treatment with inhaled nitric oxide	Jun, 2029 (6 years from now)
US8293284	MALLINCKRODT HOSP	Methods of reducing the risk of occurrence of pulmonary edema in term or near-term neonates in need of treatment with inhaled nitric oxide	Jun, 2029 (6 years from now)
US8846112	MALLINCKRODT HOSP	Methods of distributing a pharmaceutical product comprising nitric oxide gas for inhalation	Jun, 2029 (6 years from now)
US8795741 (Pediatric)	MALLINCKRODT HOSP	Methods for treating patients who are candidates for inhaled nitric oxide treatment	Dec, 2029 (6 years from now)
US8282966 (Pediatric)	MALLINCKRODT HOSP	Methods of reducing the risk of occurrence of pulmonary edema in children in need of treatment with inhaled nitric oxide	Dec, 2029 (6 years from now)
US8293284 (Pediatric)	MALLINCKRODT HOSP	Methods of reducing the risk of occurrence of pulmonary edema in term or near-term neonates in need of treatment with inhaled nitric oxide	Dec, 2029 (6 years from now)
US8431163 (Pediatric)	MALLINCKRODT HOSP	Methods of reducing the risk of occurrence of pulmonary edema associated with inhalation of nitric oxide gas	Dec, 2029 (6 years from now)
US8846112 (Pediatric)	MALLINCKRODT HOSP	Methods of distributing a pharmaceutical product comprising nitric oxide gas for inhalation	Dec, 2029 (6 years from now)
US8291904	MALLINCKRODT HOSP	Gas delivery device and system	Jan, 2031 (7 years from now)
US8776794	MALLINCKRODT HOSP	Nitric oxide delivery device	Jan, 2031 (7 years from now)
US8573210	MALLINCKRODT HOSP	Nitric oxide delivery device	Jan, 2031 (7 years from now)
US8573209	MALLINCKRODT HOSP	Gas delivery device and system	Jan, 2031 (7 years from now)
US9265911	MALLINCKRODT HOSP	Gas delivery device and system	Jan, 2031 (7 years from now)
US9295802	MALLINCKRODT HOSP	Gas delivery device and system	Jan, 2031 (7 years from now)
US8776795	MALLINCKRODT HOSP	Gas delivery device and system	Jan, 2031 (7 years from now)
US9408993	MALLINCKRODT HOSP	Nitric oxide delivery device	Jan, 2031 (7 years from now)
US8291904 (Pediatric)	MALLINCKRODT HOSP	Gas delivery device and system	Jul, 2031 (8 years from now)
US8776794 (Pediatric)	MALLINCKRODT HOSP	Nitric oxide delivery device	Jul, 2031 (8 years from now)
US8573210 (Pediatric)	MALLINCKRODT HOSP	Nitric oxide delivery device	Jul, 2031 (8 years from now)
US9295802 (Pediatric)	MALLINCKRODT HOSP	Gas delivery device and system	Jul, 2031 (8 years from now)
US9408993 (Pediatric)	MALLINCKRODT HOSP	Nitric oxide delivery device	Jul, 2031 (8 years from now)
US9265911 (Pediatric)	MALLINCKRODT HOSP	Gas delivery device and system	Jul, 2031 (8 years from now)
US8573209 (Pediatric)	MALLINCKRODT HOSP	Gas delivery device and system	Jul, 2031 (8 years from now)
US8776795 (Pediatric)	MALLINCKRODT HOSP	Gas delivery device and system	Jul, 2031 (8 years from now)
US9279794	MALLINCKRODT HOSP	Systems and methods for compensating long term sensitivity drift of electrochemical gas sensors exposed to nitric oxide	Feb, 2034 (10 years from now)
US9279794 (Pediatric)	MALLINCKRODT HOSP	Systems and methods for compensating long term sensitivity drift of electrochemical gas sensors exposed to nitric oxide	Aug, 2034 (11 years from now)
US9770570	MALLINCKRODT HOSP	Apparatus and method for monitoring nitric oxide delivery	May, 2036 (12 years from now)
US9770570 (Pediatric)	MALLINCKRODT HOSP	Apparatus and method for monitoring nitric oxide delivery	Nov, 2036 (13 years from now)

Do you want to check out INOMAX patents from before 2022?

Market Authorisation Date: 23 December, 1999

Treatment: A method of reducing the risk of pulmonary edema in patients in need of treatment with inhaled nitric oxide; A method of providing a predetermined concentration of nitric oxide to a patient; A method ...

Dosage: GAS;INHALATION